14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $4.27 $5.34 Monday, 22nd Apr 2024 BCRX stock ended at $4.41. This is 0.451% less than the trading day before Friday, 19th Apr 2024. During the day the stock fluctuated 4.10% from a day low at $4.39 to a day high of $4.57.
90 days $4.27 $6.35
52 weeks $4.27 $9.07

Historical BioCryst Pharmaceuticals prices

Date Open High Low Close Volume
Aug 13, 2021 $16.50 $16.88 $16.07 $16.15 2 477 447
Aug 12, 2021 $15.50 $16.68 $15.45 $16.64 3 981 490
Aug 11, 2021 $16.14 $16.23 $15.21 $15.58 5 629 621
Aug 10, 2021 $16.81 $17.30 $15.15 $15.21 8 010 506
Aug 09, 2021 $17.57 $18.12 $17.44 $17.65 2 711 231
Aug 06, 2021 $17.80 $18.48 $17.31 $17.61 5 767 094
Aug 05, 2021 $15.74 $17.81 $15.10 $17.65 8 678 708
Aug 04, 2021 $16.88 $17.02 $16.11 $16.26 2 701 451
Aug 03, 2021 $16.41 $16.81 $16.00 $16.76 1 817 350
Aug 02, 2021 $16.15 $16.57 $16.08 $16.10 1 778 336
Jul 30, 2021 $16.76 $16.83 $16.07 $16.12 2 457 189
Jul 29, 2021 $16.84 $17.27 $16.68 $16.76 1 884 635
Jul 28, 2021 $16.99 $17.19 $16.67 $16.82 2 151 011
Jul 27, 2021 $17.33 $17.33 $16.55 $16.80 2 180 003
Jul 26, 2021 $17.39 $17.55 $17.09 $17.25 2 171 031
Jul 23, 2021 $17.09 $17.61 $16.76 $17.26 3 223 852
Jul 22, 2021 $16.46 $17.30 $16.33 $16.97 3 385 608
Jul 21, 2021 $16.15 $16.70 $16.06 $16.53 2 414 458
Jul 20, 2021 $15.34 $16.29 $15.25 $16.24 3 115 819
Jul 19, 2021 $15.19 $15.92 $15.07 $15.40 2 702 065
Jul 16, 2021 $15.88 $15.92 $15.51 $15.61 1 787 185
Jul 15, 2021 $15.57 $16.02 $15.40 $15.80 2 774 219
Jul 14, 2021 $15.90 $16.10 $15.52 $15.63 2 467 716
Jul 13, 2021 $15.65 $16.12 $15.60 $15.87 1 736 495
Jul 12, 2021 $16.43 $16.54 $15.77 $15.80 2 426 827
Click to get the best stock tips daily for free!

About BioCryst Pharmaceuticals

BioCryst Pharmaceuticals BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX9930, an oral factor D inhibitor, which is in Phase II... BCRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT